Prospective Evaluation of a Breast Cancer Risk Model Integrating Classical Risk Factors and Polygenic Risk in 15 Cohorts from Six Countries
Montserrat García‐Closas(Institute of Cancer Research), Anika Hüsing(German Cancer Research Center), Minouk J. Schoemaker(Institute of Cancer Research), Marjanka K. Schmidt(University of Cambridge), Kara Martin(Cancer Council Victoria), Graham G. Giles(The University of Melbourne), Aaron D. Norman(Mayo Clinic in Arizona), Jenny Chang‐Claude(Universität Hamburg), Susan M. Gapstur(Centre international de recherche sur le cancer), Michael E. Jones(Institute of Cancer Research), Stacey J. Winham(Mayo Clinic), Anthony J. Swerdlow(Institute of Cancer Research), Rudolf Kaaks(German Cancer Research Center), Mikael Eriksson(Herlev Hospital), Antonis C. Antoniou(Weatherford College), Kay‐Tee Khaw(University of Cambridge), Kamila Czene(Karolinska Institutet), Roger L. Milne(The University of Melbourne), D. I. Chasman(Brigham and Women's Hospital), Kathy R. Brandt(Memorial Sloan Kettering Cancer Center), Thomas U. Ahearn(Harvard University), Elke M. van Veen(Manchester Academic Health Science Centre), Marike Gabrielson(Karolinska Institutet), Myrto Barrdahl(German Cancer Research Center), Douglas F. Easton(University of Cambridge), Min Shi(University of Iowa), Nasim Mavaddat(MRC Epidemiology Unit), Elaine F. Harkness(Manchester Academic Health Science Centre), Mark N. Brook(Institute of Cancer Research), Per Hall(Karolinska Institutet), Peter Kraft(National Cancer Institute), Parichoy Pal Choudhury(American Cancer Society), Dale P. Sandler(University of North Carolina at Chapel Hill), Jacques Simard(Université Laval), Chi Gao(North China University of Science and Technology Affiliated Hospital), Brian D. Carter(American Cancer Society), Celine M. Vachon(Leiden University Medical Center), Robert J. MacInnis(The University of Melbourne), Nick Orr(United States Department of Health and Human Services), Mia M. Gaudet(Cancer Prevention Institute of California), Christopher G. Scott(Mayo Clinic in Florida), Carla H. van Gils(University Medical Center Utrecht), D. Gareth Evans(Manchester Academic Health Science Centre), Melissa C. Southey(The University of Melbourne), Julie E. Buring(Brigham and Women's Hospital), Paul M. Ridker(Herlev Hospital), Sarah Sampson(Breast Cancer Care), Clarice R. Weinberg(National Institute of Environmental Health Sciences)
Cited by 3
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k